Key result
Cardiac uptake of [123I]MIBG was significantly lower in patients with Parkinson's disease and autonomic failure compared with controls.
Why the study?
Is cardiac uptake of [123I]MIBG impaired in patients with Parkinson's disease and autonomic failure compared to controls?
Case-Control (n=10)
Is cardiac uptake of [123I]MIBG impaired in patients with Parkinson's disease and autonomic failure compared to controls?
Answers are grounded in this paper and cite their sources.
Scintigraphy with [123I]MIBG demonstrates impaired postganglionic sympathetic cardiac innervation in patients with Parkinson's disease and autonomic failure.
OBJECTIVE: To selectively investigate postganglionic sympathetic cardiac neurons in patients with Parkinson's disease and autonomic failure. MATERIAL AND METHODS: Metaiodobenzylguanidine (MIBG) is a pharmacologically inactive analogue of noradrenaline, which is similarly metabolized in noradrenergic neurons. Therefore the uptake of radiolabelled MIBG represents not only the localization of postganglionic sympathetic neurons but also their functional integrity. Ten patients with Parkinson's disease and autonomic failure underwent standardized autonomic testing, assessment of catecholamine plasma levels and scintigraphy with [123I]MIBG. RESULTS: The cardiac uptake of MIBG, as demonstrated by the heart/mediastinum ratio, was significantly lower in patients in comparison with controls. Scintigraphy with MIBG allowed the selective in-vivo investigation of postganglionic sympathetic cardiac efferents in patients with autonomic failure, a procedure which was previously confined to post-mortem examination. CONCLUSION: These findings point to a relevant postganglionic pattern of involvement of the autonomic nervous system (ANS) in Parkinson's disease and autonomic failure.
No takes yet. Share an insight, caveat, or question.
Braune et al. (1998) conducted a case-control in Parkinson's disease and autonomic failure (n=10). Parkinson's disease with autonomic failure vs. Controls was evaluated on Cardiac uptake of MIBG (heart/mediastinum ratio). Cardiac uptake of [123I]MIBG was significantly lower in patients with Parkinson's disease and autonomic failure compared with controls.
Synapse has enriched 10 related papers. Consider them for comparative context: